AI Travel Platform Navan Targets $923 Million IPO, Aims for $6.9 Billion Valuation
AI Travel Platform Navan Targets $923 Million IPO, Aims for $6.9 Billion Valuation
Navan, the AI-powered corporate travel and expense management software provider, has officially...
Ramaco Resources Eyes Secondary Offering Amid Strong Demand for U.S. Metallurgical Coal
Ramaco Resources, Inc. (NASDAQ: METC), a leading U.S. producer of metallurgical coal, is reportedly exploring a secondary equity offering to capitalize on the recent...
Chronic Inflammatory Disease Biotech Evommune Files for a $100 Million IPO
California-based biotechnology company Evommune Inc. has filed for an initial public offering (IPO) worth up to $100 million, marking a major step in its...
Turn Therapeutics to Direct List on Nasdaq, Bringing Innovative Wound and Skin Treatments to Public Markets
Turn Therapeutics, a biotechnology company specializing in wound care and dermatology, is set to begin trading on the Nasdaq today (October 8) through a...
Molecular diagnostics company BillionToOne files for a $100 million IPO
Molecular diagnostics company BillionToOne Inc. has filed for an initial public offering (IPO) in the United States, seeking to raise up to $100 million...
